We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Announces “Stalking Horse” Agreement for the Sale of Zokinvy® (lonafarnib) Patient Access to Zokinvy® to Continue Uninterrupted PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger...
Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan PR Newswire PALO ALTO...
Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split PR Newswire PALO ALTO, Calif., Jan. 4, 2024 PALO ALTO, Calif., Jan. 4, 2024 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | -0.755 | -30.4435483871 | 2.48 | 2.5977 | 1.66 | 169110 | 2.08248127 | CS |
12 | -4.365 | -71.6748768473 | 6.09 | 8.2672 | 1.1 | 163765 | 2.03056888 | CS |
26 | -8.475 | -83.0882352941 | 10.2 | 14.33697 | 1.1 | 180972 | 5.93422136 | CS |
52 | -31.275 | -94.7727272727 | 33 | 43.35 | 1.1 | 301260 | 16.26459511 | CS |
156 | -255.075 | -99.328271028 | 256.8 | 300.639 | 1.1 | 434546 | 120.82347753 | CS |
260 | -321.075 | -99.4656133829 | 322.8 | 474.6 | 1.1 | 382939 | 183.09586741 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions